<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 is a serious human infectious disease of global concern. As of 7 April 2020, SARS-CoV-2 has infected a total of 134,784 patients globally at least (
 <xref ref-type="fig" rid="F3">Figure 3</xref>D &amp; G). The COVID-19 outbreak poses a serious challenge to China and the whole world; it has profoundly affected public health. Although the overall mortality rate of SARS-CoV-2 appears to be lower than that of SARS-CoV and MERS-CoV (
 <xref rid="T1" ref-type="table">Table 1</xref>), the transmissibility of COVID-19 is more rapid. Moreover, the fatality rate of elderly patients with reduced immunity or chronic diseases is as high as 15% [
 <xref rid="B6" ref-type="bibr">6</xref>]. In addition, asymptomatic carriers may be a potential source of infection, sustaining a local epidemic and global spread [
 <xref rid="B83" ref-type="bibr">83</xref>]. Therefore, COVID-19 may cause disruptions to the global public health system for an extended period of time.
</p>
